Tissue-specific transplantation antigen P35B (TSTA3) immune response-mediated metabolism coupling cell cycle to postreplication repair network in no-tumor hepatitis/cirrhotic tissues (HBV or HCV infection) by biocomputation

Immunologic Research

Volumn 52, Issue 3, 2012, Pages 258-268

  Wang, Lin ^a   Huang, Juxiang ^a   Jiang, Minghu ^b   Lin, Hong ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b TSINGHUA UNIVERSITY   (China)

Author keywords

Biocomputation; Immune response mediated metabolism coupling cell cycle to postreplication repair network; No tumor hepatitis cirrhotic tissues (HBV or HCV infection); Tissue specific transplantation antigen P35B (TSTA3)

Indexed keywords

ANTIGEN; ARACHIDONIC ACID; BAP1 PROTEIN; BRCA1 PROTEIN; CKS1B PROTEIN; CYCLIN DEPENDENT KINASE; ELAVL3 PROTEIN; GAS7 PROTEIN; INSULIN; INTERLEUKIN 8; LEUKOTRIENE; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MEMBRANE PROTEIN; MINICHROMOSOME MAINTENANCE PROTEIN 2; MONOCARBOXYLATE TRANSPORTER 4; MS4A2 PROTEIN; NQO1 PROTEIN; NTN1 PROTEIN; OCRL PROTEIN; PHOSPHOLIPASE A2; PHOSPHOLIPID; PLA2G1B PROTEIN; PROTEIN P21; PROTEIN P53; REG1A PROTEIN; REG3A PROTEIN; SSTR5 PROTEIN; TISSUE SPECIFIC TRANSPLANTATION ANTIGEN P35B; TP53I11 PROTEIN; UNCLASSIFIED DRUG; VCAN PROTEIN;

ACTIN FILAMENT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; B LYMPHOCYTE ACTIVATION; BIOSYNTHESIS; CANCER CELL CULTURE; CCNB2 PROTEIN; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CELL MIGRATION; CELLULAR IMMUNITY; CHEMICAL PARAMETERS; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DNA DAMAGE; ENZYME ACTIVITY; GENE REGULATORY NETWORK; GENETIC TRANSCRIPTION; HEPATITIS B; HEPATITIS C; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFLAMMATION; INSULIN RELEASE; LEUKOTRIENE BIOSYNTHESIS; LIPID METABOLISM; LIVER CIRRHOSIS; METABOLISM; NEUTROPHIL CHEMOTAXIS; PHOSPHOLIPID METABOLISM; POSTREPLICATION REPAIR NETWORK; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUMOR IMMUNITY; XENOBIOTIC METABOLISM;

CARBOHYDRATE EPIMERASES; CELL CYCLE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; KETONE OXIDOREDUCTASES; LIVER; LIVER CIRRHOSIS; MALE;

EID: 84864285304     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-012-8337-z     Document Type: Article

References (50)

1. Ming-Ju H, et al. Hepatitis C virus E2 protein induce reactive oxygen species (ROS)-related fibrogenesis in the HSC-T6 hepatic stellate cell line. J Cell Biochem. 2011;112(1):233-43.
2. Svegliati-Baroni G, et al. Insulin resistance and necroinflammation drives ductular reaction and epithelial-mesenchymal transition in chronic hepatitis C. Gut. 2011;60(1):108-15.
3. Bauer T, Sprinzl M, Protzer U. Immune control of hepatitis B virus. Dig Dis. 2011;29(4):423-33.
4. Feng J, et al. Correction: high frequency of CD4CXCR5 TFH cells in patients with immune-active chronic hepatitis B. PLoS ONE. 2011;6(7):e21698.
5. Feng J, et al. High frequency of CD4+CXCR5+TFH cells in patients with immune-active chronic hepatitis B. PLoS ONE. 2011;6(7):e21698.
6. Roque-Cuellar MC, et al. Cellular immune responses and occult infection in seronegative heterosexual partners of chronic hepatitis C patients. J Viral Hepat. 2011;18(10):E541-9.
7. Svicher V, et al. Role of hepatitis B virus genetic barrier in drugresistance and immune-escape development. Dig Liver Dis. 2011;43(12):975-83.
8. Tsamandas AC, et al. Oval cell proliferation in cirrhosis in rats. An experimental study. Hepatol Res. 2007;37(9):755-64.
9. Donato MF, et al. High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity. Hepatology. 2001;34(3):523-8.
10. Sangiovanni A, et al. Hepatocyte proliferation and risk of hepatocellular carcinoma in cirrhotic patients. Am J Gastroenterol. 2001;96(5):1575-80.
11. Toda K, et al. Induction of hepatic stellate cell proliferation by LPS-stimulated peripheral blood mononuclear cells from patients with liver cirrhosis. J Gastroenterol. 2000;35(3):214-20.
12. Delhaye M, et al. Hepatocyte proliferative activity in human liver cirrhosis. J Hepatol. 1999;30(3):461-71.
13. Borzio M, et al. Hepatocyte proliferation rate is a powerful parameter for predicting hepatocellular carcinoma development in liver cirrhosis. Mol Pathol. 1998;51(2):96-101.
14. de Paula AM, et al. Cell proliferation markers in the odontogenic keratocyst: effect of inflammation. J Oral Pathol Med. 2000; 29(10):477-82.
15. Yu E, et al. Acute inflammation of the proliferative zone of gastric mucosa in Helicobacter pylori gastritis. Pathol Res Pract. 1999;195(10):689-97.
16. Chang M. Dual roles of estrogen metabolism in mammary carcinogenesis. BMB Rep. 2011;44(7):423-34.
17. Gaglio D, et al. Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth. Mol Syst Biol. 2011;7:523.
18. Stieber D, Abdul Rahim SA, Niclou SP, Novel ways to target brain tumour metabolism. Expert Opin Ther Targets. 2011; 15(10):1227-39.
19. Yoshizaki T. A novel immune evasion mechanism of LMP-1, an EBV-primary oncogene, in nasopharyngeal carcinoma. Adv Otorhinolaryngol. 2011;72:157-9.
20. Alavian S-M, et al. Lipid profiles and hepatitis C viral markers in HCV-infected thalassemic patients. Gut Liver. 2011;5(3):348-55.
21. Amet T, et al. CD59 incorporation protects hepatitis C virus againstcomplement-mediated destruction.Hepatology. 2012;55(2): 354-63.
22. Doi, H., et al., Dysfunctional B-cell activation in cirrhosis due to hepatitis C infection associated with disappearance of CD27 + B-cell population. Hepatology, 2011.
23. Bagan JV, et al. Malignant transformation of proliferative verrucous leukoplakia to oral squamous cell carcinoma: A series of 55 cases. Oral Oncol. 2011;47(8):732-5.
24. Ernst CW, et al. Malignant transformation of an abdominal inflammatory myofibroblastic tumor with distant metastases in a child. Jbr-Btr. 2011;94(2):78-80.
25. Guck J, et al. Optical deformability as an inherent cell marker for testing malignant transformation and metastatic competence. Biophys J. 2005;88(5):3689-98.
26. Hritz I, et al. Increased p53 expression in the malignant transformation of Barrett's esophagus is accompanied by an upward shift of the proliferative compartment. Pathol Oncol Res. 2009; 15(2):183-92.
27. Iyengar B. Expression of proliferating cell nuclear antigen (PCNA): proliferative phase functions and malignant transformation of melanocytes. Melanoma Res. 1994;4(5):293-5.
28. Katori H, Nozawa A, Tsukuda M. Cell proliferation, apoptosis, and apoptosis inhibition in malignant transformation of sinonasal inverted papilloma. Acta Otolaryngol. 2007;127(5):540-6.
29. LeMay DR, Bucci MN, Farhat SM. Malignant transformation of recurrent meningioma with pulmonary metastases. Surg Neurol. 1989;31(5):365-8.
30. Lopez-Jornet P, Alonso FC. Proliferative verrucous leukoplakia and malignant transformation. J Eur Acad Dermatol Venereol. 2008;22(9):1138-9.
31. Muller PE, et al. Malignant transformation of a benign enchondroma of the hand to secondary chondrosarcoma with isolated pulmonary metastasis. Acta Chir Belg. 2004;104(3):341-4.
32. Nagai M, et al. Proliferative potential and malignant transformation of ganglioglioma: immunohistochemical studies by MIB- 1 and p53 staining. Noshuyo Byori. 1995;12(2):141-9.
33. You N, et al. Tg737 inhibition results in malignant transformation in fetal liver stem/progenitor cells by promoting cell-cycle progression and differentiation arrest. Mol Carcinog. 2011. doi: 10.1002/mc.20839.
34. Jacobsen EA, et al. Growth, differentiation, and malignant transformation of pre-B cells mediated by inducible activation of v-Abl oncogene. J Immunol. 2006;176(11):6831-8.
35. Pollett JB, et al. Malignant transformation of multipotent musclederived cells by concurrent differentiation signals. Stem Cells. 2007;25(9):2302-11.
36. Zheng H, et al. Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma. Cold Spring Harb Symp Quant Biol. 2008;73:427-37.
37. Ozaki T, et al. Intramedullary spinal cord metastasis following spontaneous malignant transformation from giant cell tumor of bone 16 years after pulmonary metastasis. J Orthop Sci. 2011; 16(1):119-24.
38. Ito H, et al. Identification of ROBO1 as a novel hepatocellular carcinoma antigen and a potential therapeutic and diagnostic target. Clin Cancer Res. 2006;12(11 Pt 1):3257-64.
39. Storey JD, A direct approach to false discovery rates. J R Stat Soc Ser B. 2002;64:479-98.
40. Wang L, et al. Survivin (BIRC5) cell cycle computational network in human no-tumor hepatitis/cirrhosis and hepatocellular carcinoma transformation. J Cell Biochem. 2011;112(5): 1286-94.
41. Wang Y, et al. Inferring gene regulatory networks from multiple microarray datasets. Bioinformatics. 2006;22(19):2413-20.
42. Sun L, et al. Glycogen debranching enzyme 6 (AGL), enolase 1 (ENOSF1), ectonucleotide pyrophosphatase 2 (ENPP2-1), glutathione S-transferase 3 (GSTM3-3) and mannosidase (MAN2B2) metabolism computational network analysis between chimpanzee and human left cerebrum. Cell Biochem Biophys. 2011;61(3): 493-505.
43. Huang J, et al. Interferon α-inducible protein 27 computational network construction and comparison between the frontal cortex of HIV encephalitis (HIVE) and HIVE-control patients. Open Genomics J. 2010; 3(1875-693X): 1-8.
44. Huang JX, Wang L, Jiang MH. TNFRSF11B computational development network construction and analysis between frontal cortex of HIV encephalitis (HIVE) and HIVE-control patients. J Inflamm (Lond). 2010;7:50.
45. Sun Y, et al. Secreted phosphoprotein 1 upstream invasive network construction and analysis of lung adenocarcinoma compared with human normal adjacent tissues by integrative biocomputation. Cell Biochem Biophys. 2010;56(2-3):59-71.
46. Sun Y, Wang L, Lui L. Integrative decomposition procedure and Kappa statistics set up ATF2 ion binding module in malignant pleural mesothelioma (MPM). Front Electr Electron Eng China. 2008;3(4):381-7.
47. Wang L, Huang J, Jiang M. RRM2 computational phosphoprotein network construction and analysis between no-tumor hepatitis/ cirrhotic liver tissues and Human Hepatocellular Carcinoma (HCC). Cell Physiol Biochem. 2010;26(3):303-10.
48. Wang L, et al. AFP computational secreted network construction and analysis between human hepatocellular carcinoma (HCC) and no-tumor hepatitis/cirrhotic liver tissues. Tumour Biol. 2010; 31(5):417-25.
49. Wang L, et al. FOS proliferating network construction in early colorectal cancer (CRC) based on integrative significant function cluster and inferring analysis. Cancer Invest. 2009;27(8):816-24.
50. Wang L, et al. Integrative decomposition procedure and Kappa statistics for the distinguished single molecular network construction and analysis. J Biomed Biotechnol. 2009;2009:726-8.